Hemingway Harry, Langenberg Claudia, Damant Jacqueline, Frost Chris, Pyörälä Kalevi, Barrett-Connor Elizabeth
Department of Epidemiology and Public Health, University College London Medical School, 1-19 Torrington Place, London WC1E 6BT, United Kingdom.
Circulation. 2008 Mar 25;117(12):1526-36. doi: 10.1161/CIRCULATIONAHA.107.720953. Epub 2008 Mar 17.
In the absence of previous international comparisons, we sought to systematically evaluate, across time and participant age, the sex ratio in angina prevalence in countries that differ widely in the rate of mortality due to myocardial infarction.
We searched MEDLINE and EMBASE until February 2006 for healthy population studies published in any language that reported the prevalence of angina (Rose questionnaire) in women and men. We obtained myocardial infarction mortality rates from the World Health Organization. A total of 74 reports of 13,331 angina cases in women and 11,511 cases in men from 31 countries were included. Angina prevalence varied widely across populations, from 0.73% to 14.4% (population weighted mean 6.7%) in women and from 0.76% to 15.1% (population weighted mean 5.7%) in men, and was strongly correlated within populations between the sexes (r=0.80, P<0.0001). Angina prevalence showed a small female excess with a pooled random-effects sex ratio of 1.20 (95% CI 1.14 to 1.28, P<0.0001). This female excess was found across countries with widely differing myocardial infarction mortality rates in women (interquartile range 12.7 to 126.5 per 100,000), was particularly high in the American studies (1.40, 95% CI 1.28 to 1.52), and was higher among nonwhite ethnic groups than among whites. This sex ratio did not differ significantly by participant's age, the year the survey began, or the sex ratio for mortality due to myocardial infarction.
Over time and at different ages, independent of diagnostic and treatment practices, women have a similar or slightly higher prevalence of angina than men across countries with widely differing myocardial infarction mortality rates.
在缺乏以往国际比较的情况下,我们试图系统评估不同心肌梗死死亡率的国家中,随时间和参与者年龄变化的心绞痛患病率的性别比。
我们检索了MEDLINE和EMBASE直至2006年2月,查找以任何语言发表的健康人群研究,这些研究报告了女性和男性心绞痛(采用罗斯问卷)的患病率。我们从世界卫生组织获取心肌梗死死亡率。共纳入来自31个国家的74份报告,其中女性心绞痛病例13331例,男性11511例。心绞痛患病率在不同人群中差异很大,女性为0.73%至14.4%(人群加权均值6.7%),男性为0.76%至15.1%(人群加权均值5.7%),且在各人群中两性之间呈强相关性(r = 0.80,P < 0.0001)。心绞痛患病率显示女性略多,合并随机效应性别比为1.20(95%可信区间1.14至1.28,P < 0.0001)。在心肌梗死死亡率差异很大的国家中均发现女性患病率较高(女性每10万人的四分位间距为12.7至126.5),在美国的研究中尤为高(1.40,95%可信区间1.28至1.52),且非白人种族群体高于白人。该性别比在参与者年龄、调查开始年份或心肌梗死死亡率的性别比方面无显著差异。
随着时间推移和在不同年龄,无论诊断和治疗方法如何,在心肌梗死死亡率差异很大的国家中,女性心绞痛患病率与男性相似或略高。